signature=39b197ff4640aa50ae6aaa292ef14e6a,miRNAs 144-3p , 34a-5p, and 206 are a useful signature fo...

Arleo EK, Schwartz PE, Hui P, McCarthy S (2015) Review of leiomyoma variants. Am J Roentgenol 205(4):912–921. https://doi.org/10.2214/AJR.14.13946

Baiocchi G, Poliseli FLV, De Brot L et al (2016) TOP2A copy number and TOP2A expression in uterine benign smooth muscle tumours and leiomyosarcoma. J Clin Pathol 69(10):884–889. https://doi.org/10.1136/jclinpath-2015-203561

Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society, Series B 57(1):289–300

Bovell L, Shanmugam C, Katkoori VR et al (2013) miRNAs are stable in formalin-fixed paraffin-embedded archival tissue specimens of colorectal cancers stored for up to 28 years. Front Biosci 4:1937–1940

Brany D, Dvorska D, Nachajova M, Slavik P, Burjanivova T (2015) Malignant tumors of the uterine corpus: molecular background of their origin. Tumor Biol 36(9):6615–6621. https://doi.org/10.1007/s13277-015-3824-1

Calvano Filho CM, Calvano-Mendes DC, Carvalho KC, Maciel GA, Ricci MD, Torres AP et al (2014) Triple-negative and luminal a breast tumors: differential expression of miR-18a-5p, miR-17-5p, and miR-20a-5p. Tumour Biol 35(8):7733–7741. https://doi.org/10.1007/s13277-014-2025-7

D’Angelo E, Prat J (2010) Uterine sarcomas: a review. Gynecol Oncol 116(1):131–139. https://doi.org/10.1016/j.ygyno.2009.09.023

Danielson LS, Menendez S, CS-O A et al (2010) A differentiation-based microRNA signature identifies leiomyosarcoma as a mesenchymal stem cell-related malignancy. Am J Pathol 177(2):908–917. https://doi.org/10.2353/ajpath.2010.091150

de Almeida BC, Garcia N, Maffazioli G, Gonzalez Dos Anjos L, Chada Baracat E, Candido Carvalho K (2017) Oncomirs expression profiling in uterine Leiomyosarcoma cells. Int J Mol Sci 19(1):52. https://doi.org/10.3390/ijms19010052

Fu YF, Du TT, Dong M et al (2009) Mir-144 selectively regulates embryonic {alpha}-hemoglobin synthesis during primitive erythropoiesis. Blood 113:1340–1349. https://doi.org/10.1182/blood-2008-08-174854

Gao J, Li N, Dong Y et al (2014) miR-34a-5p suppresses colorectal cancer metastasis and predicts recurrence in patients with stage II/III colorectal cancer. Oncogene 34(31):4142–4152. https://doi.org/10.1038/onc.2014.348

Garcia N, Bozzini N, Baiocchi G, da Cunha IW, Maciel GA, Soares Junior JM et al (2016) May sonic hedgehog proteins be markers for malignancy in uterine smooth muscle tumors? Hum Pathol 50:43–50. https://doi.org/10.1016/j.humpath.2015.08.026.

Gockley AA, Rauh-Hain JA, Del Carmen MG (2014) Uterine leiomyosarcoma. Int J Gynecol Cancer. https://doi.org/10.1097/IGC.0000000000000290

Guled M, Pazzaglia L, Borze I et al (2014) Differentiating soft tissue leiomyosarcoma and undifferentiated pleomorphic sarcoma: a miRNA analysis. Genes Chromosom Cancer 53(8):693–702. https://doi.org/10.1002/gcc.22179

Hart M, Rheinheimer S, Leidinger P et al (2016) Identification of miR-34a-target interactions by a combined network based and experimental approach. Oncotarget 7(23):34288–34299. https://doi.org/10.18632/oncotarget.9103.

Kowalewska M, Bakula-Zalewska E, Chechlinska M et al (2013) microRNAs in uterine sarcomas and mixed epithelial-mesenchymal uterine tumors: a preliminary report. Tumor Biol 34(4):2153–2160. https://doi.org/10.1007/s13277-013-0748-5

Kurman R, Carcangiu ML, Herrington CSYR (2014) Tumours of the uterine corpus – Mesenchymal tumours. In: WHO Classification of tumours of female reproductive organs, vol 6, 4th edn. IARC, Lyon, pp 135–147. (WHO/IARC Classification of Tumours

Misso G, Di Martino MT, De Rosa G et al (2014) Mir-34: a new weapon against cancer? Mol Ther Nucleic Acids 3:e194. https://doi.org/10.1038/mtna.2014.47.

Nagy ZB, Wichmann B, Kalmár A, Barták BK, Tulassay Z, Molnár B (2016) miRNA isolation from FFPE specimens: a technical comparison of miRNA and total RNA isolation methods. Pathol Oncol Res 22(3):505–513. https://doi.org/10.1007/s12253-015-0027-4

Nakatani F, Ferracin M, Manara MC et al (2012) miR-34a predicts survival of Ewing’s sarcoma patients and directly influences cell chemo-sensitivity and malignancy. J Pathol 226(5):796–805. https://doi.org/10.1002/path.3007

Novetsky AP, Powell MA (2013) Management of sarcomas of the uterus. Curr Opin Oncol 25(5):546–552. https://doi.org/10.1097/CCO.0b013e328363e0ef

Pu Y, Zhao F, Wang H, Cai W, Gao J (2017) MiR-34a-5p promotes the multi-drug resistance of osteosarcoma by targeting the CD117 gene. Oncotarget 7(19):28420–28434. https://doi.org/10.18632/oncotarget.20599.

Ravid Y, Formanski M, Smith Y, Reich R, Davidson B (2016) Uterine leiomyosarcoma and endometrial stromal sarcoma have unique miRNA signatures. Gynecol Oncol 140(3):512–517. https://doi.org/10.1016/j.ygyno.2016.01.001

Serrano C, George S (2013) Leiomyosarcoma. Hematol Oncol Clin North Am. https://doi.org/10.1016/j.hoc.2013.07.002

Si W, Li Y, Shao H et al (2016) MiR-34a inhibits breast cancer proliferation and progression by targeting Wnt1 in Wnt/β-catenin signaling pathway. Am J Med Sci 352(2):191–199. https://doi.org/10.1016/j.amjms.2016.05.002

Starega-Roslan J, Koscianska E, Kozlowski P, Krzyzosiak WJ (2011) The role of the precursor structure in the biogenesis of microRNA. Cell Mol Life Sci 68(17):2859–2871. https://doi.org/10.1007/s00018-011-0726-2

Syring I, Bartels J, Holdenrieder S, Kristiansen G, Müller SC, Ellinger J (2015) Circulating serum miRNA (miR-367-3p, miR-371a-3p, miR-372-3p and miR-373-3p) as biomarkers in patients with testicular germ cell cancer. J Urol 193(1):331–337. https://doi.org/10.1016/j.juro.2014.07.010

Vidal AF, Cruz AM, Magalhães L, Pereira AL, Anaissi AK, Alves NC et al (2016) Hsa-miR-29c and hsa-miR-135b differential expression as potential biomarker of gastric carcinogenesis. World J Gastroenterol 22(6):2060–2070. https://doi.org/10.3748/wjg.v22.i6.2060

Voorhoeve PM, Le Sage C, Schrier M et al (2006) A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell 124:1169–1181

Wang L, Zhu M-J, Ren A-M et al (2014) A ten-microRNA signature identified from a genome-wide microRNA expression profiling in human epithelial ovarian cancer. PLoS One 9(5):e96472. https://doi.org/10.1371/journal.pone.0096472

Xiao F, Chen J, Lian C, Han P, Zhang C (2015) Tumor necrosis factor-related apoptosis-inducing ligand induces cytotoxicity specific to osteosarcoma by microRNA response elements. Mol Med Rep 11(1):739–745. https://doi.org/10.3892/mmr.2014.2710

Zhang LY, Lee VHF, Wong AMG et al (2013) Microrna-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTEN. Carcinogenesis 34(2):454–463. https://doi.org/10.1093/carcin/bgs346

Zhang S-Y, Lu Z-M, Lin Y-F et al (2016) miR-144-3p, a tumor suppressive microRNA targeting ETS-1 in laryngeal squamous cell carcinoma. Oncotarget 7(10):11637–11650. https://doi.org/10.18632/oncotarget.7025